Doxepin Hydrochloride Capsule
Product Images NDC 71335-2817

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Doxepin Hydrochloride (NDC 71335-2817). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pic (56645f3c 452a 404f Ad51 2dab95f23e6e 01)

FDA Label Image

Image (56645f3c 452a 404f Ad51 2dab95f23e6e 316 1)

Image (56645f3c 452a 404f Ad51 2dab95f23e6e 316 1)
Not available.*
FDA Label Image

Image (56645f3c 452a 404f Ad51 2dab95f23e6e 316 2)

FDA Label Image

Image (56645f3c 452a 404f Ad51 2dab95f23e6e 316 3)

FDA Label Image

Image (56645f3c 452a 404f Ad51 2dab95f23e6e 316 4)

FDA Label Image

Image (56645f3c 452a 404f Ad51 2dab95f23e6e 316 5)

FDA Label Image

Label (Lbl713352817)

Label (Lbl713352817)
Each capsule contains Doxepin Hydrochloride, USP equivalent to 25 mg of Doxepin. The capsules should be stored at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). It is important to protect the capsules from light and dispense them in a tight, light-resistant container with a child-resistant closure. Keep all drugs out of the reach of children. The package insert contains dosage and use information and can be scanned for prescribing details. Repackaged by Bryant Ranch Prepack, Inc. and manufactured by Mankind Pharma Ltd.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.